Umemura K, Komiya I, Nakadori S, Chow S Y
Jpn J Antibiot. 1977 Sep;30(9):650-6.
Pharmacokinetic behavior of dibekacin after intramuscular administration was studied in nine healthy volunteers by cross over administrations of three dosage levels (1 mg(pot.)/kg, 1.5 mg(pot.)/kg and 2 mg(pot.)/kg). Drug concentrations in serum and urinary recoveries were measured and those data were analysed pharmacokinetically. The serum levels of this drug were in proportion to dosage, and the pharmacokinetic parameters were almost the same through the three dosage levels. Then it was considered that the pharmacokinetic behaviors of dibekacin were almost the same within the range of these dosage levels. No significant difference was found between the body clearances calculated from the data of serum levels, and the renal clearances calculated from the data of urinary recovery and serum levels. Therefore it is considered that the elimination of the drug from blood is almost due to renal excretion.
通过对9名健康志愿者进行三种剂量水平(1mg(效价)/kg、1.5mg(效价)/kg和2mg(效价)/kg)的交叉给药,研究了肌注地贝卡星后的药代动力学行为。测定了血清中的药物浓度和尿回收率,并对这些数据进行了药代动力学分析。该药物的血清水平与剂量成正比,并且在三种剂量水平下的药代动力学参数几乎相同。因此可以认为,在这些剂量水平范围内,地贝卡星的药代动力学行为几乎相同。从血清水平数据计算得到的机体清除率与从尿回收率和血清水平数据计算得到的肾清除率之间没有显著差异。因此,可以认为药物从血液中的消除几乎是由于肾排泄。